Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
Na Hee Lee, Meong Hi Son, Young Bae Choi, Eunsang Yi, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo
Cancer Res Treat. 2016;48(4):1399-1407.   Published online 2016 Mar 24     DOI: https://doi.org/10.4143/crt.2015.481
Citations to this article as recorded by Crossref logo
Circulating tumor cells in neuroblastoma: Current status and future perspectives
Ran Yang, Shan Zheng, Rui Dong
Cancer Medicine.2022;[Epub]     CrossRef
A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
Jia Li, Hao Qiao, Fei Wu, Shiyu Sun, Cong Feng, Chaofan Li, Wanjun Yan, Wei Lv, Huizi Wu, Mengjie Liu, Xi Chen, Xuan Liu, Weiwei Wang, Yifan Cai, Yu Zhang, Zhangjian Zhou, Yinbin Zhang, Shuqun Zhang
Frontiers in Immunology.2022;[Epub]     CrossRef
Liquid biomarkers for the management of paediatric neuroblastoma: an approach to personalised and targeted cancer therapy
Ernest Osei, Nidaa Al-Ani, Aladdin Al-Asady, Susan Dang
Journal of Radiotherapy in Practice.2021; 20(2): 217.     CrossRef
Construction of a novel methylation‐related prognostic model for colorectal cancer based on microsatellite status
Lichao Cao, Erfei Chen, Hezi Zhang, Ying Ba, Bianbian Yan, Tong Li, Jin Yang
Journal of Cellular Biochemistry.2021; 122(12): 1781.     CrossRef
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff, Wei Li, Moreno di Marco, Erin Runbeck, Hau Truong, Jugmohit S. Toor, Sarvind Tripathi, Son Nguyen, Helena Shen, Tiffany Noel, Nicole L. Church, Amber
Nature.2021; 599(7885): 477.     CrossRef
Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
Hana Lim, Meong Hi Son, Ju Kyung Hyun, Hee Won Cho, Hee Young Ju, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo
Journal of Korean Medical Science.2020;[Epub]     CrossRef
The challenge of defining “ultra-high-risk” neuroblastoma
Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau-Couanet, Wendy B. London, Meredith S. Irwin
Pediatric Blood & Cancer.2019; 66(4): e27556.     CrossRef
Opportunities and challenges of circulating biomarkers in neuroblastoma
Ricky M. Trigg, Jacqui A. Shaw, Suzanne D. Turner
Open Biology.2019; 9(5): 190056.     CrossRef
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study
Daniel A. Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, Martin Elliot, Aleksandra Wieczorek, Geneviève Laureys, Per Kogner, Josef Malis, Ell
Pediatric Blood & Cancer.2018; 65(11): e27363.     CrossRef
Favorable prognostic role of tropomodulins in neuroblastoma
Paola Bettinsoli, Giulia Ferrari-Toninelli, Sara Anna Bonini, Michela Guarienti, Davide Cangelosi, Luigi Varesio, Maurizio Memo
Oncotarget.2018; 9(43): 27092.     CrossRef
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
Atif A. Ahmed, Lei Zhang, Naresh Reddivalla, Maxine Hetherington
Pediatric Hematology and Oncology.2017; 34(3): 165.     CrossRef